INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2022

Three months of resveratrol supplementation did not reduce hormonal migraine burden, disability, or improve quality of life.

A randomized, double-blind, placebo-controlled crossover trial evaluated the effect of consuming 75 mg of resveratrol twice daily for three months versus placebo in 62 hormonal migraineurs. Outcomes included the hormonal migraine burden index (HMBI), Headache Impact Test-6™, Migraine Disability Assessment, and Migraine-Specific Quality of Life. No significant differences were observed between resveratrol and placebo for HMBI (p = 0.895) or any secondary disability and quality-of-life measures.

Study type
Randomized, double-blind, placebo-controlled crossover trial
Who was studied
62 hormonal migraineurs (mean age: 37.5 ± 0.8 years)
What was measured
Hormonal migraine burden index, disability, and quality of life

THE PAPER

A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine.

Dzator JSA, Howe PRC, Coupland KG, Wong RHX. Nutrients, 2022.

PubMed 35565731 ↗DOI 10.4103/0972-2327.182302 ↗

Brain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.